Long Valley, NJ, United States of America

Michael S Kopreski

USPTO Granted Patents = 40 



Average Co-Inventor Count = 1.5

ph-index = 20

Forward Citations = 1,675(Granted Patents)


Location History:

  • Kalamazoo, MI (US) (2000)
  • Portage, MI (US) (2003 - 2005)
  • Long Valley, NJ (US) (2001 - 2014)

Company Filing History:


Years Active: 2000-2014

Loading Chart...
Loading Chart...
Loading Chart...
40 patents (USPTO):Explore Patents

Title: Innovations of Michael S. Kopreski: Pioneering Cancer Detection Technologies

Introduction: Michael S. Kopreski, an accomplished inventor based in Long Valley, NJ, is notable for his significant contributions to the field of cancer diagnostics. With an impressive portfolio of 40 patents, he has dedicated his career to innovative methodologies that enhance the detection and evaluation of cancer.

Latest Patents: Among his latest contributions are groundbreaking inventions that focus on the use of extracellular ribonucleic acid (RNA) extracted from plasma or serum for cancer detection. These methodologies enable the qualitative and quantitative detection of tumor-derived or associated extracellular RNA in humans and animals. Specifically, his inventions facilitate the identification, monitoring, and evaluation of cancer or premalignant conditions through the extraction and analysis of circulating RNA found in blood plasma or serum. This advancement represents a significant leap in cancer diagnostics, allowing for more effective monitoring without the necessity of prior knowledge regarding the presence of cancerous tissues.

Career Highlights: Michael has built a distinguished career characterized by his innovative approaches to biomedical research. His work has proven essential in enhancing the accuracy and efficiency of cancer evaluations through RNA analysis. This research has not only garnered numerous patents but has also played a crucial role in advancing the diagnostic landscape for cancer.

Collaborations: Throughout his career, Michael has collaborated with notable professionals in the field, including Christopher D. Gocke and Floyd A. Benko. Additionally, he has contributed to various organizations, such as Oncomedx, Inc. and the Penn State Research Foundation, where he applied his expertise in developing technology that has the potential to transform cancer detection.

Conclusion: Michael S. Kopreski's innovative spirit and dedication to improving cancer diagnostics through the extraction and analysis of RNA have made substantial impacts in this vital field. With 40 patents to his name and a career marked by pioneering work, he continues to inspire future innovations in biomedical research and cancer evaluation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…